Display options
Cite
Kaufman J, Tyagi V, Anthony M, et al. State of the art in intravesical therapy for lower urinary tract symptoms. Rev Urol. 2010;12(4):e181-9
Kaufman, J., Tyagi, V., Anthony, M., Chancellor, M. B., & Tyagi, P. (2010). State of the art in intravesical therapy for lower urinary tract symptoms. Reviews in urology, 12(4), e181-9.
Kaufman, Jonathan, et al. "State of the art in intravesical therapy for lower urinary tract symptoms." Reviews in urology vol. 12,4 (2010): e181-9.
Kaufman J, Tyagi V, Anthony M, Chancellor MB, Tyagi P. State of the art in intravesical therapy for lower urinary tract symptoms. Rev Urol. 2010;12(4):e181-9. PMID: 21234261; PMCID: PMC3020280.
Copy Download .nbib Format: NLM
Share it on

Rev Urol. 2010;12(4):e181-9.

State of the art in intravesical therapy for lower urinary tract symptoms.

Reviews in urology

Jonathan Kaufman, Vikas Tyagi, Michele Anthony, Michael B Chancellor, Pradeep Tyagi

PMID: 21234261 PMCID: PMC3020280

Abstract

Intravesical therapy is the routine first-line treatment for effectively delaying or preventing the recurrence of bladder cancer. This route of drug administration has also shown tremendous promise in the treatment of interstitial cystitis/painful bladder syndrome (IC/PBS) and potentially overactive bladder to justify investments for further improvements. This review takes a bird's eye view into the current status of intravesical therapy, with emphasis on liposomal nanoparticles, in diseases associated with lower urinary tract symptoms (LUTS). Ongoing efforts to advance the field of intravesical drug delivery include development of sustained-release drug implants and efforts to improve delivery of biotechnological products including large protein acting as neurotoxins and small interfering RNAs.

Keywords: Bladder cancer; Interstitial cystitis; Intravesical therapy; Lower urinary tract symptoms; Painful bladder syndrome

References

  1. J Urol. 2009 Aug;182(2):786-92 - PubMed
  2. Mayo Clin Proc. 2009 Aug;84(8):702-6 - PubMed
  3. FEBS Lett. 2003 May 8;542(1-3):132-6 - PubMed
  4. Neurourol Urodyn. 2009;28(3):209-13 - PubMed
  5. Br J Urol. 1983 Oct;55(5):488-92 - PubMed
  6. J Biomed Mater Res. 2000 May;50(2):171-7 - PubMed
  7. J Inflamm (Lond). 2009 Aug 19;6:23 - PubMed
  8. Klin Monbl Augenheilkd. 2004 Oct;221(10):825-36 - PubMed
  9. Biochim Biophys Acta. 2002 Jun 13;1563(1-2):7-17 - PubMed
  10. J Urol. 2004 Jan;171(1):20-2 - PubMed
  11. J Urol. 1996 Oct;156(4):1496-501 - PubMed
  12. Eur Urol. 2006 Dec;50(6):1183-93; discussion 1193 - PubMed
  13. Am J Physiol Renal Physiol. 2006 Mar;290(3):F703-9 - PubMed
  14. Ophthalmology. 2009 Sep;116(9):1630-7 - PubMed
  15. Urology. 2005 Jan;65(1):45-8 - PubMed
  16. Clin Pharmacol Ther. 2009 May;85(5):544-7 - PubMed
  17. Neurourol Urodyn. 2010 Mar;29(3):391-4 - PubMed
  18. Curr Drug Deliv. 2005 Oct;2(4):369-81 - PubMed
  19. J Neurosci. 2006 Oct 18;26(42):10847-55 - PubMed
  20. Expert Opin Pharmacother. 2010 Apr;11(6):947-58 - PubMed
  21. Urology. 2009 Feb;73(2):421-6 - PubMed
  22. J Urol. 2009 Oct;182(4):1393-400 - PubMed
  23. Klin Monbl Augenheilkd. 2006 Dec;223(12):974-83 - PubMed
  24. J Urol. 2004 Sep;172(3):945-8 - PubMed
  25. Urology. 2006 Sep;68(3):463-9 - PubMed
  26. J Pediatr Urol. 2007 Dec;3(6):438-42 - PubMed
  27. BJU Int. 2002 Sep;90(4):381-5 - PubMed
  28. Pharm Res. 2004 May;21(5):832-7 - PubMed
  29. Med Hypotheses. 2001 Aug;57(2):135-8 - PubMed
  30. Am J Physiol Renal Physiol. 2006 Oct;291(4):F741-9 - PubMed
  31. Int J Pharm. 2005 Aug 26;300(1-2):125-30 - PubMed
  32. J Clin Invest. 2005 Apr;115(4):978-85 - PubMed
  33. Int J Urol. 2003 Oct;10 Suppl:S35-8 - PubMed
  34. J Immunol. 2005 Feb 1;174(3):1153-8 - PubMed
  35. J Urol. 1998 Mar;159(3):1074-8 - PubMed
  36. Neurourol Urodyn. 2004;23(2):180-2 - PubMed
  37. Urology. 2010 Mar;75(3):547-50 - PubMed
  38. Trends Biotechnol. 1995 Dec;13(12):527-37 - PubMed
  39. J Urol. 2004 Jan;171(1):483-9 - PubMed
  40. Am J Physiol Renal Physiol. 2008 Sep;295(3):F826-36 - PubMed
  41. J Urol. 1990 Jan;143(1):139-42 - PubMed
  42. J Urol. 1999 Jul;162(1):3-11 - PubMed
  43. Biochem Soc Trans. 1976;4(2):256-9 - PubMed
  44. J Urol. 1990 Jun;143(6):1252-6 - PubMed
  45. Mol Pharm. 2006 Jul-Aug;3(4):398-406 - PubMed
  46. Mol Biol Cell. 2002 Mar;13(3):830-46 - PubMed
  47. Eye (Lond). 2008 Jun;22(6):761-7 - PubMed
  48. J Urol. 2004 Oct;172(4 Pt 1):1529-32 - PubMed
  49. J Int Med Res. 2009 Nov-Dec;37(6):1823-30 - PubMed

Publication Types